SCHEMBL29469701

SCHEMBL29469701

CCOc1ccc(C)cc1S(=O)(=O)NC(=O)c1cc2c(F)cc(N3CCC3)cc2o1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
POLB P06746 1/20 0.43
KAT6A Q92794 2/20 0.38
NPSR1 Q6W5P4 1/20 0.37
MAPT P10636 4/20 0.37
LMNA P02545 3/20 0.37
TP53 P04637 2/20 0.36
MAPK1 P28482 2/20 0.36
ALPL P05186 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24333640 1.00 TSHR (0.43) TSHRMEN1KMT2APOLBKAT6A
SCHEMBL29469617 0.92 LMNA (0.41) TSHRMEN1KMT2AKAT6AMAPT
SCHEMBL24334334 0.92 LMNA (0.41) TSHRMEN1KMT2AKAT6AMAPT
SCHEMBL24334414 0.91 LMNA (0.48) TSHRMEN1KMT2APOLBKAT6A
SCHEMBL24333774 0.90 ALDH1A1 (0.44) TSHRMEN1KMT2APOLBNPSR1
SCHEMBL24333954 0.90 TP53 (0.42) TSHRMEN1KMT2AKAT6AMAPT
SCHEMBL24333735 0.90 TP53 (0.36) MEN1KMT2APOLBKAT6ANPSR1
SCHEMBL24334463 0.90 ALDH1A1 (0.37) POLBNPSR1MAPTLMNATP53
SCHEMBL24334361 0.90 ALDH1A1 (0.39) TSHRMEN1KMT2APOLBMAPT
SCHEMBL29469664 0.90 ALDH1A1 (0.44) TSHRMEN1KMT2ANPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP claimed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO claimed
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed